Skip to content
The Nexus
DossierENTITY

Quadria Capital

Coverage of Quadria Capital in the Nexus archive.

Earliest in view: May 21 · 09:59 UTCMost recent: May 21 · 09:59 UTC
Co-mentioned in this coverage
Recent coverage
  • BUSINESSMay 21 · 09:59 UTCBLOOMBERG
    Quadria-Backed Aragen Life Said to Plan $300 Million India IPO

    Aragen Life Sciences, backed by private equity firm Quadria Capital, is planning to launch an initial public offering (IPO) in India with a target size of $300 million. The company is a laboratory and life sciences organization preparing to go public in the Indian market.

Quadria Capital · Dossier · The Nexus